P K Baum Selected Research

Fidexaban

9/2003	Effect of vascular injury on inhibition of venous thrombosis with ZK-807834, a direct inhibitor of factor Xa.
2/2001	A novel synthetic inhibitor of factor Xa decreases early reocclusion and improves 24-h patency after coronary fibrinolysis in dogs.
5/2000	Effects of ZK-807834, a novel inhibitor of factor Xa, on arterial and venous thrombosis in rabbits.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

P K Baum Research Topics

Disease

4	Thrombosis (Thrombus) 09/2003 - 05/2000
2	Vascular System Injuries 09/2003 - 05/2000
2	Venous Thrombosis (Deep-Vein Thrombosis) 09/2003 - 05/2000
1	Wounds and Injuries (Trauma) 05/2001
1	Hemorrhage 02/2001
1	Surgical Wound 05/2000

Drug/Important Bio-Agent (IBA)

3	FidexabanIBA 09/2003 - 05/2000
3	Factor Xa (Coagulation Factor Xa)IBA 09/2003 - 05/2000
2	CopperIBA 09/2003 - 05/2000
1	Thromboplastin (Tissue Factor)IBA 09/2003
1	FibrinIBA 05/2001
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 05/2001
1	Heparin (Liquaemin)FDA LinkGeneric 02/2001
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 02/2001
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 05/2000
1	tick anticoagulant peptideIBA 05/2000
1	(2S)- 2- (4- (((3S)- 1- acetimidoyl- 3- pyrrolidinyl)oxy)phenyl)- 3- (7- amidino- 2- naphtyl)propanoic acidIBA 05/2000

Therapy/Procedure

1	Catheters 09/2003